Subscribe
SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes
Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes
Impact of the EMPA-REG Study in Type 2 Diabetes
Lowering the Risk of Venous Thromboembolism With Ovarian Cancer Treatment
1.0 Credit / Psychiatry
1.5 Credit / Hematologic Cancer, Oncology
1.5 Credit / Pain Management/Opioids
0.5 Credit / Neurology
1.0 Credit / Cardiology
1.0 Credit / Oncology, Hematology, Hematologic Cancer
1.5 Credits / General Pharmacy
2.0 Credits / General Pharmacy
2.0 Credits / Pain Management
1.5 Credits / Neurology, Psychiatry
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
1.5 Credits / Hematologic Cancer, Hematology, Oncology
1.5 Credits / Oncology, Hematology
1.5 Credits / Cardiology
1.5 Credits / HIV/AIDS, Infectious Disease
1.5 Credits / Ophthalmology/Optometry
1.5 Credits / Breast Cancer, Oncology, Women's Health
1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology
1.5 Credits / Psychiatry
1.5 Credits / Women's Health
1.5 Credits / Immunization, Infectious Disease, Pulmonology
1.5 Credits / Immunology, Allergy
1.5 Credits / Cardiology, Rare Diseases
1.5 Credits / Immunology, Pulmonology
1.5 Credits / Pulmonology
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
1.5 Credits / Immunology
1.5 Credits / Gastroenterology, Immunology
1.5 Credits / Gastroenterology
1.0 Credit / Immunology, Nephrology
1.5 Credit / Ophthalmology/Optometry
1.0 Credit / Pain Management/Opioids
2.0 Credits / Pain Management/Opioids
259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512
609-716-7777
© 2025 MJH Life Sciences®
All rights reserved.